Everything below concerns copper(II) complex. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-19. Numbers and descriptions here follow the published literature rather than marketing material.
Routine characterisation relies on reversed-phase high-performance liquid chromatography for peptide purity, paired with mass spectrometry for identity confirmation. Ultraviolet-visible spectroscopy detects the metal centre through its absorption band in the visible region, and inductively coupled plasma mass spectrometry quantifies total copper so that a metal-to-peptide ratio can be calculated. Amino acid analysis confirms the expected residue composition. Together these techniques establish concentration, identity, and stoichiometry, but none of them directly reports biological activity.
Quality specifications for research material commonly state peptide purity, copper stoichiometry, counter-ion identity, and residual water content. Frequent counter-ions include acetate and trifluoroacetate, which differ in mass and in their effect on solubility and handling. Whether batch-to-batch differences in reported responses trace to these parameters or to assay conditions remains an open question, since published comparisons rarely control for all of them at once. Independent verification therefore normally pairs a purity measurement with an elemental copper measurement on the same lot.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
| Property | Value | Notes |
|---|---|---|
| Typical peptide purity | 95% or higher by HPLC | Research-grade material; varies by supplier |
| Copper-to-peptide ratio | Approximately 1 to 1 | Determined by elemental analysis plus peptide assay |
| Visible absorption | Roughly 525 to 600 nm | Position shifts with pH and coordination state |
| Common counter-ions | Acetate, trifluoroacetate | Affect mass, solubility, and handling behaviour |
| Preferred storage form | Lyophilised powder, desiccated | Cold and dark; solutions are markedly less stable |
Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.
Routine handling calls for minimizing freeze-thaw cycles and preparing solutions shortly before use. Glass or inert plastic containers reduce adsorption and metal leaching. Working stocks are often kept at 2–8 °C for short periods, while long-term reference material stays at −20 °C or below. Light protection is prudent because prolonged exposure may accelerate oxidation of the peptide. Documentation of lot number, concentration, and preparation date supports reproducibility in laboratory work.
Analytical verification typically combines reversed-phase high-performance liquid chromatography with ultraviolet-visible detection. The copper complex absorbs visible light near 600–630 nm, giving a characteristic blue signal. Mass spectrometry confirms molecular mass and can detect free peptide or mismatched copper stoichiometry. Copper content is often measured independently by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy. Purity, counterion identity, and residual solvents are additional quality-control parameters that methods may address.
Characterizing GHK-Cu requires methods that distinguish the intact complex from free peptide and unbound copper. UV-visible absorption around 600 nm provides a rapid check for copper coordination, while circular dichroism reports on peptide secondary structure. Mass spectrometry confirms the peptide mass and can detect copper adducts under carefully controlled conditions. Electron paramagnetic resonance is particularly informative for Cu(II) because it reveals the ligand field symmetry. No single technique fully defines the complex, so laboratories combine orthogonal methods.
Stability of GHK-Cu in solution depends on pH, temperature, buffer composition, and oxygen exposure. The copper center can undergo reduction or dissociation, especially in the presence of strong metal chelators such as EDTA. Aqueous solutions are often prepared fresh or stored frozen to limit degradation. Lyophilized solid is more stable than liquid formulations, but it can absorb moisture and should be kept dry. Light exposure may also affect copper complexes, though the effect is often modest.
The peptide portion consists of three amino acids: glycine, histidine and lysine. Copper(II) coordinates through the imidazole nitrogen of histidine, the alpha-amino group of glycine and a deprotonated amide nitrogen of the backbone, producing a roughly square-planar geometry. This arrangement gives the complex its characteristic blue-to-violet colour and helps it resist dissociation in water. Reported stability constants are high, although values differ between studies because of differences in ionic strength and measurement method.
The International Nomenclature of Cosmetic Ingredients lists the substance as copper tripeptide-1, the name that appears on most topical product labels. Related designations include copper peptide and GHK-Cu, and the hyphenated form is common in research literature. In cosmetics the material is regulated as an ingredient rather than as a drug, so products may reach the market without evidence of the effects claimed for them. Whether those effects are clinically meaningful is an open question, since most supportive data come from laboratory work and small trials.
In April 1955, Eisenhower proposed a special economic fund for Asia. To implement Congress's August 1954 decision that technical assistance for developing countries should be put back under the State Department, Eisenhower abolished FOA in May 1955 and created the new International Cooperation Administration (ICA) in the State Department. This separated development assistance from military assistance.
The United States Food and Drug Administration (FDA) has defined bioequivalence as, "the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study."
==== South Africa ==== There are two major brands of cider produced in South Africa, Hunters and Savanna. They are produced and distributed through Heineken, which acquired Distell in April 2023. Hunters Gold was first introduced in South Africa in 1988 as an alternative to beer. The Hunters range includes Hunters Dry, Hunters Gold, Hunters Export and Hunters Edge launched in April 2017. Savanna Dry was introduced in 1996 and also comes in Light, Angry Lemon and Alc Free variants, excluding other limited run variants like Loco, Blackbeard and Neat. The Elgin Valley east of Cape Town grows around 60% of all the apples in South Africa. As a result, the region also has a vibrant craft cider scene, with brands like Sxollie, Everson's, Cluver & Jack, Windermere and Terra Madre all produced in the area. Sxollie Cider is increasingly being exported around the world, especially to the UK. Almost 90% of all the Sxollie produced is exported. Sxollie is pronounced like "skollie". Sxollie's Pink Lady Cider won Supreme Champion at the International Cider Challenge in 2019. Windermere Cider began brewing in 1994 and is regarded as the oldest craft cider brewery in South Africa. Loxtonia Cider, produced in the Ceres area, was crowned the overall champion at the 11th International Cider Challenge in London in 2021. Loxtonia's Alexandra Blush Méthode Traditionelle was named Supreme Champion for 2021 and won the Rosé Trophy as the best cider made in the rosé style.
Sources: en.wikipedia.org
==== NMR techniques ==== The most common NMR techniques used when discriminating chiral compounds are 1H-NMR, 19F-NMR and 13C-NMR. 1H-NMR is the primary technique used to assign absolute configuration. 19F-NMR is almost exclusive applied to optical purity studies, and 13C-NMR is primarily used to characterize substrates that do not have protons that are directly bonded to an asymmetrical carbon atom.
=== 2014–2015: AFL Tribunal hearing against players === After Essendon's Federal Court challenge was dismissed in October 2014 (but while Hird's was still ongoing), ASADA issued fresh show-cause notices to the players on 17 October 2014. The players had two weeks to respond to the notices and exercised their right not to respond. On 13 November 2014, the Anti-Doping Rule Violation Panel concluded that sufficient evidence existed against the players, and they were placed on the register of findings. The following day, the AFL issued infraction notices to the players. The players faced a closed hearing of the AFL Tribunal over several sessions between December 2014 and February 2015. The burden of proof fell to ASADA, and the required standard of proof to return a guilty verdict was "comfortable satisfaction". Upon issuing of the infractions notices on 14 November, players could accept provisional suspensions, meaning they would be ineligible to play AFL-sanctioned matches until the Tribunal hearing was finalised, but that they could continue to train in the pre-season, and that time served during the provisional suspension would be counted as part of any final suspension.
=== Radiological scope === Contrast agents with therapeutic properties have been under development for several years. One example is the design of contrast agents capable of releasing a chemotherapeutic agent locally at the target site, triggered by a stimulus provided by the operator. This localized approach aims to increase treatment efficacy and minimize side effects. For instance, ultrasound-based contrast media, such as microbubbles, can accumulate in hypervascularized tissues and release the active ingredient in response to ultrasound waves, thus targeting a specific area chosen by the sonographer. Another approach involves linking monoclonal antibodies (capable of targeting different molecular targets) to nanoparticles. This strategy enhances the drug's affinity and specificity towards the target and enables visualization of the treatment area, such as using superparamagnetic iron oxide particles detectable by magnetic resonance imaging. Additionally, these particles can be designed to release chemotherapy agents specifically at the site of binding, producing a local synergistic effect with antibody action. Integrating these methods with medical-nuclear techniques, which offer greater imaging sensitivity, may aid in target identification and treatment monitoring.
Sources: en.wikipedia.org
Inductively coupled plasma mass spectrometry or atomic absorption spectroscopy gives total copper after acid digestion. Combining that value with a peptide concentration from chromatography or amino acid analysis yields the metal-to-peptide ratio.
The colour arises from electronic transitions within the copper(II) d orbital set, which absorb visible light. The absorption maximum shifts with pH and with the number of nitrogen donors bound, so the spectrum serves as a rough probe of coordination state.
Aqueous solutions degrade faster than dry powder, because hydrolysis, oxidation, and metal dissociation all proceed in water. Dividing solutions into small aliquots and freezing them limits repeated freeze-thaw cycles. Exact shelf lives are not well established and depend on concentration and buffer.
It is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, a sequence of three amino acids. The copper ion is held by the histidine imidazole, the terminal amino group, and an amide nitrogen. The bound form is distinct from the free peptide in charge, color, and stability.